Condition
Refractory Chronic Cough clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Refractory Chronic Cough clinical trials that are recruiting, at sites in 4 countries (most in United States (3), China (1), Canada (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Refractory Chronic Cough clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Nalbuphine ER for chronic cough in people with RCC | Phase 2 | Kelowna, British Columbia and 20 other locations | Recruiting | Jun 26, 2026 |
| BLU-5937 for Refractory Chronic Cough: 24-Week Test in Adults (China Extension) | Phase 3 | Leshan, Sichuan and 37 other locations | Recruiting | Jun 16, 2026 |
| Cough Management app for refractory or unexplained chronic cough | — | Wilmington, Delaware | Recruiting | Jul 17, 2025 |
| Behavioral Cough Suppression Therapy with or without an inhaled aid for refractory chronic cough | Phase 2 | Aurora, Colorado and 2 other locations | Recruiting | May 7, 2025 |
| Testing Duloxetine and Amitriptyline for Chronic Cough Relief | Phase 2 | Rochester, Minnesota | Recruiting | Nov 5, 2021 |
All recruiting trials (5)
-
Nalbuphine ER for chronic cough in people with RCC
This study tests whether extended-release nalbuphine helps people with unexplained, long-standing cough that hasn’t improved with other treatments.
-
BLU-5937 for Refractory Chronic Cough: 24-Week Test in Adults (China Extension)
This study tests whether BLU-5937 can reduce 24-hour cough frequency in adults with refractory or unexplained chronic cough.
-
Cough Management app for refractory or unexplained chronic cough
This trial will see if using a smartphone Cough Management program plus a smartwatch for four weeks lowers coughing and improves quality of life in adults 21–80 with refractory or unexplained chronic cough.
-
Behavioral Cough Suppression Therapy with or without an inhaled aid for refractory chronic cough
This study tests whether adding an inhaled substance to behavioral cough suppression helps people with persistent chronic cough see if it works better than behavior therapy alone.
-
Testing Duloxetine and Amitriptyline for Chronic Cough Relief
This study is testing if two medications, Duloxetine and Amitriptyline, can help people with a stubborn chronic cough feel better.
Related topics
Quick answers
How many Refractory Chronic Cough clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), China (1 trial), Canada (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.